rawfin.tv
Lundbeck Reportedly Eyes Acquisition of Xeris Biopharma
MarketsstocksAI Generated

Lundbeck Reportedly Eyes Acquisition of Xeris Biopharma

By rawfin.tv Markets Desk||Updated |1 min read|AI-assisted · Methodology

H Lundbeck A/S has reportedly shown interest in acquiring Xeris Biopharma Holdings Inc. Xeris Biopharma is a commercial-stage drugmaker.

lundbeckxeris-biopharmam&apharmaceuticalsstocks

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks